
*Manifestations of clinical symptoms, including visual disturbances, or headache, should prompt a possible diagnosis of intracranial hypertension. If increased intracranial pressure is suspected during treatment with lymecycline, administration should be immediately stopped. Benign intracranial hypertension has been reported with tetracyclines, with possible symptoms of headache, vomiting, visual disturbances including blurred vision, scotoma, diplopia or permanent loss of vision.
Some adverse effects are reported with tetracycline therapy in general: Dental dyschromia and/or enamel hypoplasia may occur if the product is administered in children younger than 8 years of age.
Haemolytic anaemia, eosinophilia and other hematologic disorders have been reported with tetracycline therapy.
Extra-renal hyperazotemia linked to an anti-anabolic effect which may be intensified by the association with diuretics has been reported with tetracycline therapy.
Systemic Lupus Erythematosus.
Pancreatitis.
View ADR Reporting Link